These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31246819)

  • 21. Caveolin-1 Controls Hyperresponsiveness to Mechanical Stimuli and Fibrogenesis-Associated RUNX2 Activation in Keloid Fibroblasts.
    Hsu CK; Lin HH; Harn HI; Ogawa R; Wang YK; Ho YT; Chen WR; Lee YC; Lee JY; Shieh SJ; Cheng CM; McGrath JA; Tang MJ
    J Invest Dermatol; 2018 Jan; 138(1):208-218. PubMed ID: 28899682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
    Lee HJ; Jang YJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
    Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
    J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between keloid growth pattern and stretching tension: visual analysis using the finite element method.
    Akaishi S; Akimoto M; Ogawa R; Hyakusoku H
    Ann Plast Surg; 2008 Apr; 60(4):445-51. PubMed ID: 18362577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas-mediated apoptotic signal transduction in keloid and hypertrophic scar.
    Lu F; Gao J; Ogawa R; Hyakusoku H; Ou C
    Plast Reconstr Surg; 2007 May; 119(6):1714-1721. PubMed ID: 17440345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth Differentiation Factor-9 Promotes Fibroblast Proliferation and Migration in Keloids through the Smad2/3 Pathway.
    Jiang Z; Yu Q; Xia L; Zhang Y; Wang X; Wu X; Gao Z
    Cell Physiol Biochem; 2016; 40(1-2):207-218. PubMed ID: 27855376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of systemic diseases, genetic disorders and lifestyle on keloids.
    Xia G; Dohi T; Abdelhakim M; Tosa M; Ogawa R
    Int Wound J; 2024 Apr; 21(4):e14865. PubMed ID: 38584345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revealing the pathogenesis of keloids based on the status: Active vs inactive.
    Oh S; Yeo E; Shim J; Noh H; Park J; Lee KT; Kim SH; Lee D; Lee JH
    Exp Dermatol; 2024 May; 33(5):e15088. PubMed ID: 38685820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keloids show regional distribution of proliferative and degenerate connective tissue elements.
    Bux S; Madaree A
    Cells Tissues Organs; 2010; 191(3):213-34. PubMed ID: 19641294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased CCN2 transcription in keloid fibroblasts requires cooperativity between AP-1 and SMAD binding sites.
    Xia W; Kong W; Wang Z; Phan TT; Lim IJ; Longaker MT; Yang GP
    Ann Surg; 2007 Nov; 246(5):886-95. PubMed ID: 17968183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keloid scarring or disease: Unresolved quasi-neoplastic tendencies in the human skin.
    Ud-Din S; Bayat A
    Wound Repair Regen; 2020 May; 28(3):422-426. PubMed ID: 31943508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
    Seleit I; Bakry OA; Samaka RM; Tawfik AS
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction may promote keloid growth.
    Noishiki C; Takagi G; Kubota Y; Ogawa R
    Wound Repair Regen; 2017 Nov; 25(6):976-983. PubMed ID: 29240273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human adipose tissue-derived stem cells inhibit the activity of keloid fibroblasts and fibrosis in a keloid model by paracrine signaling.
    Liu J; Ren J; Su L; Cheng S; Zhou J; Ye X; Dong Y; Sun S; Qi F; Liu Z; Pleat J; Zhai H; Zhu N
    Burns; 2018 Mar; 44(2):370-385. PubMed ID: 29029852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
    Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
    Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keloid and hypertrophic scarring may result from a mechanoreceptor or mechanosensitive nociceptor disorder.
    Ogawa R
    Med Hypotheses; 2008 Oct; 71(4):493-500. PubMed ID: 18614294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue stiffening promotes keratinocyte proliferation through activation of epidermal growth factor signaling.
    Kenny FN; Drymoussi Z; Delaine-Smith R; Kao AP; Laly AC; Knight MM; Philpott MP; Connelly JT
    J Cell Sci; 2018 May; 131(10):. PubMed ID: 29669739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.